Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nutra Pharma has signed Innovatix as a contractual distributer of its over-the-counter (OTC) pain reliever Nyloxin across US.
Subscribe to our email newsletter
Nyloxin is indicted for the treatment of moderate to severe (Stage 2) chronic pain.
Currently, Nyloxin is available in the US as an oral spray for treating back pain, neck aches, headaches, joint pain, migraines, and neuralgia, and as a topical gel for treating joint pain, neck pain, arthritis pain, and pain from repetitive stress.
Nutra Pharma chairman and CEO Rik Deitsch said Nyloxin will allow seniors to reduce their pain and inflammation without the subsequent loss of cognitive function.